Latest debt-to-equity ratio
HCW Biologics Debt-to-equity ratio
Direct answer
HCW Biologics's debt-to-equity ratio is 88.34%.
The verified market snapshot reports 88.34%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 24, 2026.
Get free HCW Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 88.34%
Explore related company data
View HCW Biologics's market capitalizationView HCW Biologics's price-to-book ratioView HCW Biologics's return on equityView HCW Biologics's dividend yieldView HCW Biologics's 52-week price rangeView HCW Biologics's revenue growthView HCW Biologics's profit marginView all HCW Biologics key metricsReturn to HCW Biologics profile